Current updates in perioperative management of intracerebral hemorrhage.
Spontaneous ICH remains a formidable disease that continues to disable and kill the majority of its victims. Treatment of the disease continues to be controversial and without any proved success, such as improvement in the disease mortality or the resulting disability in survivors. Primary prevention is the most effective medical intervention. Nevertheless, as the population continues to age and patients remain undertreated for hypertension, the incidence of ICH likely will increase, resulting in significant socioeconomic impact on society in the coming years. It is imperative that more research be conducted to improve treatment and outcomes of patients who have ICH. Unlike ischemic stokes or other causes of hemorrhagic stroke, such as SAH, where major advancement of treatment has led to improved outcomes, the increased incidence of ICH has not been matched with any considerable improvement in treatment. This burden to improve therapeutic interventions for patients who have ICH should be shared by all neurosurgeons, stroke neurologists, and critical care physicians who care for these patients on a regular basis. It is hoped that early diagnosis and resuscitation, prevention of hematoma growth, selective surgery or minimally invasive clot evacuation, and judicious critical care and rehabilitation will combine to lessen the burden of this disease.
Hsieh
Patrick C
PC
Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, 676 North St. Clair Street, Suite 2210, Chicago, IL 60611, USA.
Awad
Issam A
IA
Getch
Christopher C
CC
Bendok
Bernard R
BR
Rosenblatt
Szymon S
SS
Batjer
H Hunt
HH
D001921:Brain / Q000473:pathology*; D002543:Cerebral Hemorrhage; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D019635:Neurosurgical Procedures; D019990:Perioperative Care